CHINA HEALTH(00673)

Search documents
中国卫生集团(00673.HK)供股获有效接纳81.1%
Ge Long Hui· 2025-09-22 12:55
格隆汇9月22日丨中国卫生集团(00673.HK)公告,供股项下提呈发售供股股份总数为147,493,428股。董 事会宣布,于2025年9月17日(星期三)下午四时正(即最后接纳时限),已接获合共10份有效接纳,涉及合 共119,689,791股供股股份,约占所有供股股份的81.1%。因此,供股认购不足额为27,803,637股供股股 份,约占所有供股股份的18.9%,并将根据补偿安排处理。根据契诺契约及承诺,张先生及包销商分别 认购392,220股及40,797,600股供股股份。 ...
中国卫生集团(00673) - (1)供股股份之有效接纳结果;及(2)补偿安排涉及之未获认购供股股份...
2025-09-22 12:45
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責,對其準確性或 完整性亦不發表任何聲明,並明確表示概不會就本公佈全部或任何部分內容產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 China Health Group Limited 中國衛生集團有限公司 (以CHG HS Limited名稱在香港經營業務) (於百慕達註冊成立之有限公司) (股份代號:673) (1)供股股份之有效接納結果; 及 (2)補償安排涉及之未獲認購供股股份數目 茲提述中國衛生集團有限公司(「本公司」)日期為二零二五年九月三日之供股章程(「供股章程」), 內容有關按於記錄日期每持有十(10)股股份獲發三(3)股供股股份之基準按發行價每股供股股份 0.10港元進行供股。除文義另有所指外,本公佈所用詞彙與供股章程所界定者具有相同涵義。 供股股份之有效接納結果 供股項下提呈發售之供股股份總數為147,493,428股。 董事會宣佈,於二零二五年九月十七日(星期三)下午四時正(即最後接納時限),已接獲合共10份 有效接納,涉及合共119,689,791股供股股份,約佔所有供股股份的81.1%。因此,供股認購不足額 為 ...
每天三分钟公告很轻松|600673,并购大动作





Shang Hai Zheng Quan Bao· 2025-09-10 16:09
Group 1 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of 100% equity in Qinhuai Data China, with a total investment of 75 billion yuan [2] - Baiyin Nonferrous Metals is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [3] - Beida Pharmaceutical intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [5] Group 2 - ST Tianmao plans to withdraw its A-share listing and transfer to the National SME Share Transfer System after delisting [5] - Goldwind Technology has approved an investment agreement for a 3GW wind-hydrogen-ammonia integration project in Inner Mongolia, with a total investment of approximately 189.2 billion yuan [6] - Langzi Co. has signed an agreement to acquire 67.5% of Chongqing Milan Baiyu Shiguang Medical Beauty Hospital for 92.475 million yuan [7] Group 3 - Dongfang Guoxin is establishing a joint venture with Beijing Shunyi Financial Holdings to focus on computing power infrastructure and services, with a registered capital of 300 million yuan [8] - ST Hezhong's chairman is under bail pending trial, but the company's operations remain unaffected [9] - Kangzhi Pharmaceutical's major shareholder is transferring 22.758 million shares at a price of 5.34 yuan per share, totaling 122 million yuan [9] Group 4 - Shenzhen Airport reported a passenger throughput of 5.807 million in August, a year-on-year increase of 4.07% [10] - Lin Yang Energy won a bid for a project with a total amount of approximately 244.08 million yuan [11] - Fullpower New Materials received a government subsidy of 20 million yuan, which is expected to positively impact its 2025 profits [14] Group 5 - BYD executives and core personnel collectively increased their holdings by 48.82 million shares, totaling 52.3278 million yuan [16] - Hualing Steel's major shareholder increased its stake by 6.90862 million shares, representing a 1% increase in ownership [16]
600673,战略入股数据服务商,估值280亿!
Zheng Quan Shi Bao· 2025-09-10 14:58
Group 1 - Dongyangguang announced a capital increase of 35 billion and 40 billion yuan for Dongshu Yihua, resulting in ownership stakes of 46.6654% and 53.3332% respectively after the increase [1] - Dongshu Yihua plans to invest the raised funds into its wholly-owned subsidiary, Shanghai Dongchuang Future Data Co., which will further invest in Dongshu Sanhao for the acquisition of 100% equity of Qinhuai Data China for 28 billion yuan [1] - After the completion of these transactions, Dongyangguang will become a shareholder of Dongshu Yihua, indirectly holding a portion of Qinhuai Data China's equity [1] Group 2 - Qinhuai Data is recognized as a leading player in the computing power sector, ranking first in three major indices: intensive development, international layout, and green low-carbon [5] - As of May 2023, Qinhuai Data's total assets were 21.871 billion yuan, with net assets of 9.504 billion yuan, and projected revenue of 6.048 billion yuan and net profit of 1.309 billion yuan for 2024 [6][7] - The acquisition of Qinhuai Data's assets is seen as a strategic move for Dongyangguang to quickly enter the data center field, enhancing its long-term competitiveness and investment value [7] Group 3 - The acquisition is part of a broader strategy to align with the national "East Data West Calculation" initiative, aiming to build a unified national computing power network [7] - Dongyangguang's technological capabilities in liquid cooling materials and supercapacitors provide a unique advantage in delivering core solutions for high-density AI computing scenarios [6] - The competitive bidding for Qinhuai Data's assets reflects strong market recognition of its value and the prospects of the national computing power strategy [5]
中国卫生集团(00673) - 截至2025年8月31日之股份发行人的证券变动月报表
2025-09-04 03:33
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 中國衛生集團有限公司 ( 以 CHG HS Limited 名稱在香港經營業務) ( 於百慕達註冊成立之有限公司) 呈交日期: 2025年9月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00673 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.1 HKD | | 10,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 100,000,000,000 | HKD ...
中国卫生集团(00673) - 致本公司非登记股东通知信函及申请表格
2025-09-02 22:19
China Health Group Limited 中國衛生集團有限公司 (Carrying on business in Hong Kong as CHG HS Limited) (Incorporated in Bermuda with limited liability) (以 CHG HS Limited 名稱在香港經營業務) (於百慕達註冊成立之有限公司) (Stock Code 股份代號:673) NOTIFICATION LETTER 通知信函 – Notice of publication of Prospectus in relation to Rights Issue on the basis of three (3) Rights Shares for every ten (10) shares held on the record date (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications ...
中国卫生集团(00673) - 致本公司登记股东通知信函及回条
2025-09-02 22:17
China Health Group Limited 中國衛生集團有限公司 (Carrying on business in Hong Kong as CHG HS Limited) (Incorporated in Bermuda with limited liability) (以 CHG HS Limited 名稱在香港經營業務) (於百慕達註冊成立之有限公司) (Stock Code 股份代號:673) NOTIFICATION LETTER 通知信函 Dear Registered Shareholders, China Health Group Limited (the "Company") – Notice of publication of Prospectus in relation to Rights Issue on the basis of three (3) Rights Shares for every ten (10) shares held on the record date (the "Current Corporate Communication") The Englis ...
中国卫生集团(00673) - 暂定配额通知书
2025-09-02 22:14
To be valid, the whole of this Provisional Allotment Letter must be returned. 本暫定配額通知書必須整份交回,方為有效。 IMPORTANT 重要提示 Reference is made to the prospectus issued by China Health Group Limited (the "Company") dated 3 September 2025 in relation to the Rights Issue (the "Prospectus"). Terms defined in the Prospectus shall have the same meanings when used herein unless the context otherwise requires. 茲提述中國衛生集團有限公司(「本公司」)日期為二零二五年九月三日就供股刊發之供股章程(「供股章程」)。除非文義另有所指,供 股章程所界定之詞彙與本暫定配額通知書所採用者具有相同涵義。 THIS PROVISIONAL ALLOTMEN ...
中国卫生集团(00673) - 按於记录日期每持有十(10)股股份获发三(3)股供股股份之基準进行供...
2025-09-02 22:08
此乃要件 請即處理 閣下如對本供股章程任何方面或須採取之行動有任何疑問,應諮詢 閣下之股票經紀或持牌證券交易商或註冊證券機構、銀行經 理、律師、專業會計師或其他專業顧問。 閣下如已售出或轉讓名下所有中國衛生集團有限公司的股份,應立即將章程文件送交買主或承讓人,或經手買賣或轉讓之銀行經 理、持牌證券交易商、註冊證券機構或其他代理商,以便轉交買主或承讓人。 各章程文件連同本供股章程附錄三「送呈公司註冊處處長之文件」一段指定之文件之副本,已根據香港法例第32章公司(清盤及雜 項條文)條例第342C條之規定送呈香港公司註冊處處長登記。香港公司註冊處處長、聯交所及香港證券及期貨事務監察委員會對 任何章程文件之內容概不負責。 登記地址位於香港以外任何司法權區之股東及身處或居於該等地址之投資者或代表擁有該等地址之股份實益擁有人持有股份之 投資者務請垂注本供股章程「董事會函件」內「海外股東之權利」一段。 待供股股份(以未繳股款及繳足股款形式)獲批准於聯交所上市及買賣且符合香港結算之股份收納規定後,供股股份(以未繳股款 及繳足股款形式)將獲香港結算接納為合資格證券,自未繳股款及繳足股款之供股股份各自開始於聯交所買賣當日或香港結 ...
中国卫生集团(00673) - (I)於二零二五年八月二十日举行之股东特别大会投票表决结果;(II)...
2025-08-20 12:31
本公佈僅作參考之用,並不構成收購、購買或認購本公司證券之邀請或要約。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責,對其準確性或 完整性亦不發表任何聲明,並明確表示概不會就本公佈全部或任何部分內容產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 China Health Group Limited 中國衛生集團有限公司 (以CHG HS Limited名稱在香港經營業務) (於百慕達註冊成立之有限公司) (股份代號:673) (I)於二零二五年八月二十日舉行之股東特別大會投票表決結果; (II)授出清洗豁免;及 (III)同意特別交易 茲提述中國衛生集團有限公司(「本公司」)日期為二零二五年七月三十一日之通函(「通函」)及股 東特別大會(「股東特別大會」)通告(「股東特別大會通告」)。除文義另有所指外,本公佈所用詞彙 與通函中所界定者具有相同涵義。 於二零二五年八月二十日舉行之股東特別大會上,股東特別大會主席要求就股東特別大會通告所 載之所有提呈決議案進行投票表決。 於股東特別大會日期,本公司已發行股份總數為491,644,763股股份,為賦予股東有權出席股東特 別大會並於大會上 ...